A nationwide survey of practicing urologists: Current management of benign prostatic hyperplasia and clinically localized prostate cancer

Journal of Urology

Volumn 158, Issue 2, 1997, Pages 488-492

  Barry, M J ^a   Fowler F J , Jr ^a   Bin, L ^a   Oesterling, J E ^a   Holtgrewe, H L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Physician's practice patterns; Practice guidelines; Prostate; Prostatic hypertrophy; Prostatic neoplasms

Indexed keywords

FINASTERIDE;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CRYOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; TRANSURETHRAL RESECTION; URINE FLOW RATE;

EID: 0030799979     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64510-5     Document Type: Article

References (22)

1. Barry M.J. Boyle P. Fourcroy J. Garraway M. Gu F.L. Harrison N.W. Jacobsen S.J. O'Leary M.P. Oishi K. Senge T. Tsukamoto T. Guess H. Epidemiology and natural history of BPH A.T.K. Cockett S. Khoury Y. Aso C. Chatelain L. Denis K. Griffiths G. Murphy The 3rd International Consultation on BPH: Proceedings 1996 Scientific Communication International Paris 21 50
2. Parker S.L. Tong T. Bolden S. Wingo P.A. Cancer statistics, 1996. CA 46 1996 5
3. Oesterling J.E. Benign prostatic hyperplasia. Medical and minimally invasive treatment options. New Engl. J. Med. 332 1995 99
4. McConnell J.D. Barry M.J. Bruskewitz R.C. Bueschen A.J. Denton S.E. Holtgrewe H.L. Lange J.L. McClennan B.L. Mebust W.K. Reilly N.J. Roberts R.G. Sacks S.A. Wasson J.H. Benign Prostatic Hyperplasia: Diagnosis and Treatment February 1994 United States Department of Health and Human Services Rockville, Maryland
5. Graves E.J. Detailed diagnoses and procedures, national hospital discharge survey: 1987 Vital Health Stat., series 13 1989 295
6. Graves E.J. Detailed diagnoses and procedures, national hospital discharge survey: 1993 Vital Health Stat., series 13 1995 128
7. Potosky A.L. Miller B.A. Albertsen P.C. Kramer B.S. The role of increasing detection in the rising incidence of prostate cancer. J.A.M.A. 273 1995 548
8. Jacobsen S.J. Katusic S.K. Bergstrahl E.J. Oesterling J.E. Ohrt D. Klee G.G. Chute C.G. Lieber M.M. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. J.A.M.A. 274 1995 1445
9. Oesterling J.E. Martin S.K. Bergstralh E.J. Lowe F.C. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. J.A.M.A. 269 1993 57
10. Barry M.J. Fleming C. Coley C.M. Wasson J.H. Fahs M.C. Oesterling J.E. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate. Urology 46 1995 2
11. Rosner B. Fundamentals of Biostatistics 3rd ed. 1990 PWS-Kent Publishing Co. Boston 293 360
12. Barry M.J. Fowler F.J. Jr. O'Leary M. Bruskewitz M.C. Holtgrewe H.L. Mebust W.K. Cockett A.T.K. The American Urological Association symptom index for benign prostatic hyperplasia. J. Urol. 148 1992 1549
13. Abrams P. In support of pressure-flow studies for evaluating men with lower urinary tract symptoms. Urology 44 1994 153
14. Gee W.F. Holtgrewe H.L. Albertsen P.C. Litwin M.S. Manyak M.J. O'Leary M.P. Painter M.R. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States. J. Urol. 154 1995 205
15. Gee W.F. Holtgrewe H.L. Albertsen P.C. Litwin M.S. Manyak M.J. O'Leary M.P. Painter M.R. Practice trends in the diagnosis and management of prostate cancer in the United States. J. Urol. 154 1995 207
16. Chybowski F.M. Larson Keller J.J. Bergstrahl E.J. Oesterling J.E. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J. Urol. 145 1991 313
17. Viswanath S. Palmer M.A. Ojha H.O. Desmond A.D. Routine estimation of prostate specific antigen prior to clinic attendance in patients with symptoms of bladder outlet obstruction. Brit. J. Urol. 72 1993 187
18. Bishoff J.T. Reyes A. Thompson I.M. Harris M.J. St Clair S.R. Gomella L. Butzin C.A. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology 45 1995 270
19. Bluestein D.L. Bostwick D.G. Bergstralh E.J. Oesterling J.E. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J. Urol. 151 1994 1315
20. Campbell S.C. Klein E.A. Levin H.S. Piedmonte M.R. Open pelvic lymph node dissection for prostate cancer: a reassessment. Urology 46 1995 352
21. Rifkin M.D. Zerhouni E.A. Gatsonis C.A. Quint L.E. Paushter D.M. Epstein J.I. Hamper U. Walsh P.C. McNeil B.J. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. New Engl. J. Med 323 1990 621
22. Levran Z. Gonzalez J.A. Diokno A.C. Jafri S.Z. Steinert B.W. Are pelvic computed tomography, bone scan, and pelvic lymphadenectomy necessary in the staging of prostate cancer? Brit. J. Urol. 75 1995 778